Inotropes or inodilators in Heart Failure with reduced Ejection Fraction (HFrEF): what to use, on whom, when and how? The clinical practice

Kristjan Karason discusses hospitalised acute heart failure patients from the EuroHeart Failure Survey II (EHFS II), the 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. He also looks at the 3 mechanisms of action of levosimendan and how it’s considered in treatment.


ESC Heart Failure 2017 resources

Videos (20)
Login/ Register Maximise Minimise